Maternal serum ADAM12s as a marker of rare aneuploidies in the first or second trimester of pregnancy

Prenatal Diagnosis

Volumn 27, Issue 13, 2007, Pages 1233-1237

  Spencer, Kevin ^a,b   Cowans, Nicholas J ^a   Stamatopoulou, Anastasia ^a  

^a KING GEORGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Free hCG; Growth factors; PAPP A; Prenatal screening; Trisomy

Indexed keywords

ADAM PROTEIN; ADAM12S PROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; AUTOANALYSIS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FETUS KARYOTYPING; FIRST TRIMESTER PREGNANCY; FLUOROMETRY; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; KARYOTYPE 45,X; KARYOTYPE 47,XXX; KARYOTYPE 47,XXY; KARYOTYPE 47,XYY; MAJOR CLINICAL STUDY; MATERNAL BLOOD; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; TRIPLOIDY; TRISOMY 13; TURNER SYNDROME;

ADAM PROTEINS; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; MEMBRANE PROTEINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; TRISOMY; TURNER SYNDROME;

EID: 37349044586     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1885     Document Type: Article

References (27)

1. Christiansen M, Spencer K, Laigaard J, Cowans NJ, Larsen SO, Wewer UM. 2007. ADAM12 as a second trimester maternal serum markers in screening for Down's syndrome. Prenat Diagn 27: 611-615.
2. Cowans NJ, Spencer K. 2007. First trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 27: 264-271.
3. Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, Wewer UM. 1998. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 273: 157-166.
4. Graham GE, Allanson JE, Gerritsen JA. 2007. Sex chromosome abnormalities. In Principles and Practice of Medical Genetics, Rimoin DL, Connor JM, Pyeritz RE, Korf BR (eds). Churchill Livingstone: Philadelphia; 1038-1057.
5. Laigaard J, Sorensen T, Frohlich C, et al. 2003. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn 23: 1086-1091.
6. Laigaard J, Christiansen M, Frohlich C, Pedersen BN, Ottesen B, Wewer UM. 2005a. The level of ADAM12 in maternal serum is an early first-trimester marker of fetal trisomy 18. Prenat Diagn 25: 45-46.
7. Laigaard J, Sorensen T, Placing S, et al. 2005b. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol 106: 144-149.
8. Laigaard J, Cuckle H, Wewer UM, Christiansen M. 2006a. Maternal serum ADAM12 levels in Down's and Edwards' syndrome pregnancies at 9-12 weeks gestation. Prenat Diagn 26: 689-691.
9. Laigaard J, Spencer K, Christiansen M, et al. 2006b. ADAM 12 as a first trimester maternal serum marker in screening for Down syndrome. Prenat Diagn 26: 973-979.
10. Lamson G, Giudice LC, Cohen P, et al. 1993. Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo. Growth Regul 3: 91-95.
11. Loechel F, Fox JW, Murphy G, Albrechtsen R, Wewer UM. 2000. ADAM 12 cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 278: 511-515.
12. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. 2005. Multicenter study of first trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk -orientated two-stage first trimester screening. Ultrasound Obstet Gynecol 25: 221-226.
13. Ong CYT, Liao AW, Spencer K, Munim S, Nicolaides KH. 2000. First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 107: 1265-1270.
14. Shi Z, Xu W, Loechel F, Wewer UM, Murphy LJ. 2000. ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3. J Biol Chem 275: 18574-18580.
15. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk for trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 18: 519-521.
16. Snijders RJM, Sundberg K, Holzgreve W, Henry G. Nicolaides KH. 1999. Maternal age and gestation specific risk for trisomy 21. Ultrasound Obstet Gynaecol 13: 167-170.
17. Spencer K. 1999. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review. BJOG 106: 1287-1293.
18. Spencer K, Nicolaides KH. 2002. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β-hCG and PAPP-A. Prenat Diagn 22: 877-879.
19. Spencer K, Cowans NJ. 2007. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy. J Matern Fetal Neonatal Med 20: 645-650.
20. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy associated plasma protein -A. Ultrasound Obstet Gynecol 13: 231-237.
21. Spencer K, Tul N, Nicolaides KH. 2000a. Maternal serum free β-hCG and PAPP-A in fetal sex chromosome defects in the first trimester. Prenat Diagn 20: 390-394.
22. Spencer K, Liao AWJ, Skentou H, Cicero S, Nicolaides KH. 2000b. Screening for triploidy by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 20: 495-499.
23. Spencer K, Bindra R, Nix ABJ, Heath VJ, Nicolaides KH. 2003a. Delta NT or NT MoM: which is the most appropriate method for calculating accurate patient specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol 22: 142-148.
24. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. 2003b. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 110: 281-286.
25. Spencer K, Bindra R, Nicolaides KH. 2003c. Maternal weight correction of maternal serum PAPP-A and free β-hCG when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 23: 851-855.
26. Tolmie JL, MacFadyen U. 2007. Clinical genetics of common autosomal trisomies. In Principles and Practice of Medical Genetics, Rimoin DL, Connor JM, Pyeritz RE, Korf BR (eds). Churchill Livingstone: Philadelphia; 1015-1037.
27. Wright DE, Bradbury I. 2005. Repeated measures screening for Down's syndrome. Br J Obstet Gynaecol 112: 80-83.